Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read more
Named profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Carboplatin in Veterinary Oncology: Infusion, Monitoring, and Safety Profile
Carboplatin is a platinum-based cytotoxic chemotherapy drug used by veterinary oncologists for selected canine and feline cancers. Its use in companion animals is veterinarian-directed and generally extra-label; it…
Read more
Doxorubicin in Veterinary Oncology: Infusion and Cumulative-Risk Profile
Doxorubicin is an anthracycline cytotoxic chemotherapy drug used by veterinary oncologists for lymphoma and several sarcomas and carcinomas. Companion-animal use is veterinarian-directed and generally extra-label, with drug-specific infusion…
Read more
Prednisone in Canine Cancer Care: A Timing and Safety Discussion
Prednisone is a prescription corticosteroid used in several veterinary cancer contexts, including components of lymphoma protocols and selected palliative plans. Its purpose, timing and taper must be defined…
Read more
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read more
Antiemetic Support During Canine Cancer Treatment
Antiemetic therapy aims to prevent or control nausea and vomiting from chemotherapy, radiation fields, anesthesia, medications, the tumor, or another disease. Drug choice and timing depend on the…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Urinalysis and Urine Culture in the Oncology Patient
Urine testing can assess concentration, blood, protein, sediment, and infection questions that matter before or during cancer treatment.
Read more
Cardiac Assessment Around Potentially Cardiotoxic Cancer Therapy
Selected cancer drugs, tumors, symptoms, and comorbidities can make a cardiovascular baseline or follow-up relevant to treatment safety.
Read more
Vincristine in Veterinary Oncology: IV Safety and Monitoring
Vincristine is a vinca alkaloid used within selected veterinary chemotherapy protocols and requires precise intravenous administration and protocol-specific monitoring.
Read more
Cyclophosphamide in Cancer Protocols: Bladder and Marrow Safety
Cyclophosphamide is an alkylating chemotherapy used in selected veterinary protocols, with blood-count, urinary, gastrointestinal, and household-safety considerations.
Read more